Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Reviva Pharmaceuticals Hldg Inc (RVPH)

Reviva Pharmaceuticals Hldg Inc (RVPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Reviva Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants

Reviva Pharmaceuticals plans to offer common stock and warrants to fund R&D and corporate needs, pending market conditions.Quiver AI SummaryReviva Pharmaceuticals Holdings, Inc. has announced a proposed...

RVPH : 1.3400 (-10.67%)
Reviva Announces Pricing of $18.0 Million Public Offering of Common Stock and Warrants

RVPH : 1.3400 (-10.67%)
Reviva Announces Proposed Public Offering

RVPH : 1.3400 (-10.67%)
Reviva Announces Positive Preliminary Topline Data for the Long-Term Open Label Extension Portion of the Phase 3 RECOVER Study Evaluating Brilaroxazine in Schizophrenia

RVPH : 1.3400 (-10.67%)
Reviva Pharmaceuticals Reports Progress on Brilaroxazine Trials and Financial Results for Q3 2024

Reviva Pharmaceuticals reports 108 patients completed a trial for schizophrenia treatment, with topline data expected December 2024.Quiver AI SummaryReviva Pharmaceuticals Holdings, Inc. announced that...

RVPH : 1.3400 (-10.67%)
Reviva Reports Third Quarter 2024 Financial Results and Recent Business Highlights

RVPH : 1.3400 (-10.67%)
10 Stocks Retailers Are Most Bullish/Bearish About On Tuesday

Earnings have largely impacted sentiment toward stocks that made it to the most bullish and bearish lists on Stocktwits Tuesday.

ALDX : 4.88 (+0.41%)
STIM : 1.3900 (+7.75%)
PGY : 8.95 (+2.76%)
QSI : 1.3000 (+0.78%)
MNOV : 2.17 (+0.46%)
AXSM : 90.73 (+1.10%)
VSAT : 8.79 (+2.45%)
ZS : 187.38 (+2.28%)
BTM : 1.7300 (-4.42%)
RVPH : 1.3400 (-10.67%)
SPY : 591.15 (+1.20%)
XBI : 91.28 (+1.64%)
Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia

RVPH : 1.3400 (-10.67%)
Reviva to Present Positive Speech Latency Data for Brilaroxazine in Schizophrenia From the Phase 3 RECOVER Trial at the CNS Summit 2024

RVPH : 1.3400 (-10.67%)
Reviva to Participate in the UBS Global Healthcare Conference

RVPH : 1.3400 (-10.67%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar